Dr. Meena A. Khan

Amir Hamrahian, M.D. is an endocrinologist with specialized experience in the treatment of adrenal and pituitary disorders. Dr. Hamrahian is located in Baltimore, Maryland. He received his medical degree from Hacettepe University in Ankara, Turkey, did his internal medicine residency at the University of North Dakota and completed his endocrinology fellowship at the Case Western Reserve University. Dr. Hamrahian is an Associate Professor of Medicine and has published more than 80 peer-reviewed articles, and has served as a co-author in developing guidelines for adrenal and pituitary disorders. He has presented at national and international conferences and has served as the principal investigator for a number of clinical research studies. Accolades received include Teacher of The Year award and Human Subject Research Annual Professional Excellence award in 2003 and 2011, respectively. Dr. Hamrahian has held roles including the chief of endocrinology in Abu Dhabi. Dr. Hamrahian is a co-director of the Adrenal Center. Dr. Hamrahian is rated as an Elite provider by MediFind in the treatment of Hyperaldosteronism. His top areas of expertise are Cushing's disease, Pituitary Tumor, Cushing's syndrome, Ectopic Cushing's syndrome, and Gamma Knife Radiosurgery.

Mihail “Misha” Zilbermint, M.D., M.B.A., F.A.C.E. is an Associate Professor of Clinical Medicine at the Division of Endocrinology, Diabetes and Metabolism, Johns Hopkins School of Medicine. He is the Director of Endocrine Hospitalists at the Johns Hopkins Community Physicians, Chief and Director of Division of Endocrinology, Diabetes and Metabolism at Suburban Hospital in Bethesda, MD. Dr. Zilbermint is known for pioneering the Endocrine Hospitalist program at Johns Hopkins Medicine following the completion of his endocrinology fellowship at the National Institutes of Health. This consultation service is dedicated to enhancing glycemic control among hospitalized patients, effectively reducing patient stays and saving the hospital hundreds of thousands of dollars. His commitment to innovation earned his specialized diabetes team the Johns Hopkins Innovations in Clinical Care Award. Over the years, Dr. Zilbermint has been sought after for his expertise in endocrinology and diabetes, with a focus on inpatient diabetes management, diabetic ketoacidosis (DKA), Hyperosmolar Hyperglycemic State (HHS), and diabetes technology. His reputation extends nationally and internationally, as he is often invited to speak at conferences and is sought after for consultations worldwide. His extensive research interests encompass diabetes initiatives, hypoglycemia reduction, continuous glucose monitoring (CGM) systems, COVID-19 vaccines and hyperglycemia, COVID-19 and diabetes, genetic causes of hypertension, primary aldosteronism, rare adrenal tumors, and the interplay between diabetes and climate change. Dr. Zilbermint leads the JHCP Academy Clinical Excellence, which helps to recognize and promote clinical excellence about community-based clinicians. Beyond his clinical and research contributions, Dr. Zilbermint is a dedicated educator. He imparts his expertise to endocrinology fellows, hospitalists, pharmacy residents, and advanced practice providers, furthering the advancement of the medical community. CVhttps://www.hopkinsmedicine.org/-/media/profiles-support/cvs/zilbermint.pdfLinkedInhttps://www.linkedin.com/in/mishazilbermint. Dr. Zilbermint is rated as an Advanced provider by MediFind in the treatment of Hyperaldosteronism. His top areas of expertise are Cushing's syndrome, Familial Hyperaldosteronism, Hyperaldosteronism, Low Blood Sugar, and Thymectomy.

Priya Kundra is an Endocrinologist in Washington, Washington, D.c.. Dr. Kundra is rated as an Advanced provider by MediFind in the treatment of Hyperaldosteronism. Her top areas of expertise are Thyroid Cancer, Follicular Thyroid Cancer, Adrenal Gland Adenoma, and Papillary Thyroid Cancer.